Early Chloroquine Retinopathy: Clinical and Functional Findings
- 1 February 1964
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 71 (2), 157-165
- https://doi.org/10.1001/archopht.1964.00970010173003
Abstract
Introduction For the past few years several synthetic antimalarials, and in particular chloroquine, have been recognized as the cause of a number of ocular disorders.1 Whitening of the lashes,2 extraocular muscle palsies affecting particularly the sixth nerve,3,4 decreased corneal sensitivity,5 corneal lesions,1,6,7 and retinal changes6,8-21 have all been related to the use of synthetic antimalarial compounds. It is of interest that ocular side effects are rarely noted in patients taking these medications in low dosages, or for short periods of time. On the other hand, ocular involvement is quite common in patients receiving these same drugs in high dosages for extended periods of time. The retinal changes induced by chloroquine are the most significant of the ocular findings. Vascular spasm, macular edema, mottling and pigmentary changes, as well as peripheral pigmentary degeneration similar to retinitis pigmentosa have all been noted.6,21,22 Loss of visualKeywords
This publication has 5 references indexed in Scilit:
- Ocular Abnormalities in Patients Treated with Synthetic Antimalarial DrugsNew England Journal of Medicine, 1963
- Chloroquine RetinopathyArchives of Ophthalmology (1950), 1963
- CENTRAL SCOTOMATA FOLLOWING CHLOROQUINE THERAPY1962
- Retinopathy associated with chloroquine phosphate therapyThe American Journal of Medicine, 1961
- Reactions to Chloroquine Observed During the Treatment of Various Dermatologic DisordersThe American Journal of Tropical Medicine and Hygiene, 1957